Literature DB >> 19219452

Caveolin, GLUT4 and insulin receptor protein content in human arm and leg muscles.

Hyo Sik Kim1, Hyo Jeong Kim, Young Sun Kim, Sang Chul Park, Roger Harris, Chang Keun Kim.   

Abstract

Recent evidence suggests that insulin sensitivity is relatively better preserved in arm muscle than in leg muscle in both healthy controls and type 2 DM, based on measurements of basal and insulin-mediated glucose clearance performed simultaneously in the two sets of muscles. It has also been reported that glucose uptake rates are higher in arm compared to leg muscles in the fasted state during normo-insulinaemia. However, the mechanism(s) for this are unknown. Currently, no information is available on the content of glucose transport proteins between arm and leg muscles. Therefore, we compared four proteins, Caveolin-1 (Cav-1), Caveolin-3 (Cav-3), GLUT4, and IR-beta, each of which plays an important role in regulating glucose transport between arm and leg muscles using muscle samples that were obtained from the deltoid (DEL) and vastus lateralis (VAS) of 14 male college pentathlon athletes before and after two swimming trials performed over 100 and 1,500 m. In the present study, we have shown the levels of Cav-1, -3, GLUT4, and IR-beta measured together for the first time in human arm and leg muscles. There was no difference in the levels of these proteins between arm and leg muscles. Cav-3, GLUT4, and IR-beta were unchanged from the resting levels after both exercise trials in DEL, while Cav-1 was increased (17%) at the end of the longer swim trial. In contrast, all measurements of Cav-1, -3, GLUT4, and IR-beta after the 1,500 m swim trial in VAS were increased, by 120, 46, 123, and 60%, respectively. These data imply that there was no functional difference in glucose transport capacity between arm and leg muscles in highly trained pentathlon athletes in the resting state. Although Cav-3, GLUT4, and IR-beta were unchanged from the resting levels at the end of both exercise trials in DEL, all measures, including Cav-1, increased after the 1,500 m swim trial in VAS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219452     DOI: 10.1007/s00421-009-1001-1

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  32 in total

1.  A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo.

Authors:  A Schlegel; M P Lisanti
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

Review 2.  Insulin signaling: GLUT4 vesicles exit via the exocyst.

Authors:  Makoto Kanzaki; Jeffrey E Pessin
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

3.  Do caveolins regulate cells by actions outside of caveolae?

Authors:  Brian P Head; Paul A Insel
Journal:  Trends Cell Biol       Date:  2006-12-05       Impact factor: 20.808

4.  Metabolism in exercising arm vs. leg muscle.

Authors:  G Ahlborg; M Jensen-Urstad
Journal:  Clin Physiol       Date:  1991-09

5.  Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulfhydryl dependence.

Authors:  M H Brooke; K K Kaiser
Journal:  J Histochem Cytochem       Date:  1970-09       Impact factor: 2.479

6.  Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle.

Authors:  M Gaster; P Poulsen; A Handberg; H D Schroder; H Beck-Nielsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-05       Impact factor: 4.310

7.  Acute exercise and GLUT4 expression in human skeletal muscle: influence of exercise intensity.

Authors:  Giorgos N Kraniou; David Cameron-Smith; Mark Hargreaves
Journal:  J Appl Physiol (1985)       Date:  2006-06-08

8.  Insulin resistance in skeletal muscles of caveolin-3-null mice.

Authors:  Jin Oshikawa; Koji Otsu; Yoshiyuki Toya; Takashi Tsunematsu; Raleigh Hankins; Jun-ichi Kawabe; Susumu Minamisawa; Satoshi Umemura; Yasuko Hagiwara; Yoshihiro Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

9.  Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells.

Authors:  Franco Capozza; Alex W Cohen; Michelle W-C Cheung; Federica Sotgia; William Schubert; Michela Battista; Hyangkyu Lee; Philippe G Frank; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2004-11-17       Impact factor: 4.249

10.  Exercise type and muscle fiber specific induction of caveolin-1 expression for insulin sensitivity of skeletal muscle.

Authors:  Yoon Sin Oh; Hyo Jeong Kim; Sung Jin Ryu; Kyung A Cho; Young Sik Park; Hyon Park; MiJung Kim; Chang Keun Kim; Sang Chul Park
Journal:  Exp Mol Med       Date:  2007-06-30       Impact factor: 8.718

View more
  4 in total

Review 1.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

2.  GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta.

Authors:  Guo Yao; Yafang Zhang; Di Wang; Ruirui Yang; Hui Sang; Linlin Han; Yuexia Zhu; Yanyan Lu; Yeke Tan; Zhanping Shang
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

3.  Caveolin-3 promotes glycometabolism, growth and proliferation in muscle cells.

Authors:  Lina Shang; Tingting Chen; Yufeng Deng; Yiyuan Huang; Yuanheng Huang; Jing Xian; Wensheng Lu; Lihui Yang; Qin Huang
Journal:  PLoS One       Date:  2017-12-05       Impact factor: 3.240

4.  Effect of type 2 diabetes mellitus caveolin-3 K15N mutation on glycometabolism.

Authors:  Yiyuan Huang; Yufeng Deng; Lina Shang; Lihui Yang; Juanjuan Huang; Jing Ma; Xianshan Liao; Hui Zhou; Jing Xian; Guining Liang; Qin Huang
Journal:  Exp Ther Med       Date:  2019-08-02       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.